Stocks in German pharmaceutical company BioNTech were up almost 18% at market close on Wednesday, reflecting optimism after a recent report said that the FDA hopes to approve the companys Covid-19 vaccine next month.
Ugur Sahin, cofounder and CEO of BioNTech….

Click here to view the original article.